Aim — To prepare a site for sponsor and regulatory inspection by identifying documentation errors, classifying their severity and ensuring GCP compliance before the auditors arrive. Duration 60 minutes · 6 departments · 14 items to inspect · 20-mark rubric · Pass 50%.
You are the Clinical Research Pharmacist preparing the hospital for a CDSCO / FDA / EMA inspection. The trial file contains deliberate mistakes. Inspect every item before the auditors arrive.
Remember the inspector’s rule: if it is not documented, it did not happen.
| Grade | Definition | Example |
|---|---|---|
| Critical | Affects participant rights, safety or well-being, or the reliability of the trial data | Expired investigational product in usable stock; unreported serious adverse event; unsigned consent |
| Major | Could affect safety or data integrity if not corrected | Transcription error between source and CRF; staff missing from the delegation log |
| Minor | Administrative; does not affect safety or data integrity | Monitoring visit report filed late, content complete |
Corrections rule: a single line strike-through, the correct value, then initials and date. Never overwrite, never use correction fluid, never obscure the original entry.
| Criteria | Marks |
|---|
The Audit Readiness Report mark combines your written audit summary (2) with correctly stating the GCP principle breached by each finding (2). Audit failure: missing a Critical finding — or downgrading one to Minor — fails the station regardless of total marks.
Inspection date · Site: Alizon Teaching Hospital, Clinical Trials Unit · Study: ALZ-CT-2026-01
Summarise the site’s audit readiness — the key findings, the risk to participants and data, and the priority corrective actions.
You may close the audit at any time — items left uninspected count as missed findings.
Inspect the site and close the audit to generate your readiness report, then write and submit your practical report.